Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

[Current surveillance policy for Barrett's oesophagus in the Netherlands].

Curvers WL, Festen HP, Hameeteman W, Meijer GA, Peters FT, siersema PD, Tilanus HW, Bergman JJ.

Ned Tijdschr Geneeskd. 2007 Aug 25;151(34):1879-84. Dutch.

PMID:
17902562
2.

[Guideline "Dyspepsia"].

de Wit NJ, van Barneveld TA, Festen HP, Loffeld RJ, van Pinxteren B, Numans ME; NHG-CBO-werkgroep 'Maagklachten'.

Ned Tijdschr Geneeskd. 2005 Jun 18;149(25):1386-92. Dutch.

PMID:
15997691
3.

Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial.

Kuipers EJ, Nelis GF, Klinkenberg-Knol EC, Snel P, Goldfain D, Kolkman JJ, Festen HP, Dent J, Zeitoun P, Havu N, Lamm M, Walan A.

Gut. 2004 Jan;53(1):12-20.

4.

[Decreasing prevalence of Helicobacter pylori: a consequence of treatment of gastroduodenal ulcers].

van der Weerd NC, Cats A, Thijs JC, Festen HP, Meuwissen SG, Kuipers EJ.

Ned Tijdschr Geneeskd. 2000 Jul 15;144(29):1385-8. Review. Dutch.

PMID:
10923145
5.

Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy.

Schenk BE, Kuipers EJ, Nelis GF, Bloemena E, Thijs JC, Snel P, Luckers AE, Klinkenberg-Knol EC, Festen HP, Viergever PP, Lindeman J, Meuwissen SG.

Gut. 2000 May;46(5):615-21.

6.

Atrophic gastritis during long-term omeprazole therapy affects serum vitamin B12 levels.

Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Bloemena EC, Sandell M, Nelis GF, Snel P, Festen HP, Meuwissen SG.

Aliment Pharmacol Ther. 1999 Oct;13(10):1343-6.

7.
8.

Hypergastrinaemia during long-term omeprazole therapy: influences of vagal nerve function, gastric emptying and Helicobacter pylori infection.

Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Bloemena E, Nelis GF, Festen HP, Jansen EH, Biemond I, Lamers CB, Meuwissen SG.

Aliment Pharmacol Ther. 1998 Jul;12(7):605-12.

9.

[Reflux esophagitis; is the preventive eradication of Helicobacter pylori needed in patients on omeprazole?].

Kuipers EJ, Klinkenberg-Knol EC, Festen HP, Meuwissen SG.

Ned Tijdschr Geneeskd. 1998 Apr 18;142(16):883-5. Dutch.

PMID:
9623181
11.

Lansoprazole, H. pylori, and atrophic gastritis.

Kuipers EJ, Klinkenberg-Knol EC, Festen HP, Meuwissen SG.

Gastroenterology. 1997 Dec;113(6):2018-9. No abstract available.

PMID:
9394746
12.

Omeprazole as a diagnostic tool in gastroesophageal reflux disease.

Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Festen HP, Jansen EH, Tuynman HA, Schrijver M, Dieleman LA, Meuwissen SG.

Am J Gastroenterol. 1997 Nov;92(11):1997-2000.

PMID:
9362179
13.

Effect of short- and long-term treatment with omeprazole on the absorption and serum levels of cobalamin.

Schenk BE, Festen HP, Kuipers EJ, Klinkenberg-Knol EC, Meuwissen SG.

Aliment Pharmacol Ther. 1996 Aug;10(4):541-5.

PMID:
8853757
14.

Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication.

Kuipers EJ, Lundell L, Klinkenberg-Knol EC, Havu N, Festen HP, Liedman B, Lamers CB, Jansen JB, Dalenback J, Snel P, Nelis GF, Meuwissen SG.

N Engl J Med. 1996 Apr 18;334(16):1018-22.

15.

Long-term sequelae of Helicobacter pylori gastritis.

Kuipers EJ, Uyterlinde AM, Peña AS, Roosendaal R, Pals G, Nelis GF, Festen HP, Meuwissen SG.

Lancet. 1995 Jun 17;345(8964):1525-8.

PMID:
7791437
16.

Pharmacological management of gastro-oesophageal reflux disease.

Klinkenberg-Knol EC, Festen HP, Meuwissen SG.

Drugs. 1995 May;49(5):695-710. Review.

PMID:
7601011
17.

Safety of acid-suppressing drugs.

Smallwood RA, Berlin RG, Castagnoli N, Festen HP, Hawkey CJ, Lam SK, Langman MJ, Lundborg P, Parkinson A.

Dig Dis Sci. 1995 Feb;40(2 Suppl):63S-80S. Review.

PMID:
7859585
18.

The prevalence of Helicobacter pylori in peptic ulcer disease.

Kuipers EJ, Thijs JC, Festen HP.

Aliment Pharmacol Ther. 1995;9 Suppl 2:59-69. Review.

PMID:
8547530
19.

Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.

Klinkenberg-Knol EC, Festen HP, Jansen JB, Lamers CB, Nelis F, Snel P, Lückers A, Dekkers CP, Havu N, Meuwissen SG.

Ann Intern Med. 1994 Aug 1;121(3):161-7.

PMID:
8017742
20.

Prevention of duodenal ulcer relapse by long-term treatment with omeprazole.

Festen HP.

Scand J Gastroenterol Suppl. 1994;201:39-41.

PMID:
8047822
21.
22.

Long-term omeprazole therapy does not affect Helicobacter pylori status in most patients.

Kuipers EJ, Klinkenberg-Knol EC, Festen HP, Lamers CB, Jansen JB, Snel P, Nelis F, Meuwissen SG.

Scand J Gastroenterol. 1993 Nov;28(11):978-80.

PMID:
8284634
23.

[Physiology and pathophysiology of intrinsic factor secretion and cobalamin (vitamin B12) absorption].

Festen HP.

Ned Tijdschr Geneeskd. 1992 Sep 19;136(38):1851-6. Review. Dutch. No abstract available.

PMID:
1407150
24.

[Prevention of gastroduodenal disorders with the use of non-steroidal anti-inflammatory drugs].

Bijlsma JW, van Berge Henegouwen GP, de Boer SY, Dijkmans BA, Festen HP, Janssen M.

Ned Tijdschr Geneeskd. 1991 Jan 12;135(2):45-8. Review. Dutch. No abstract available.

PMID:
1990306
25.
26.

Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis.

Jansen JB, Klinkenberg-Knol EC, Meuwissen SG, De Bruijne JW, Festen HP, Snel P, Lückers AE, Biemond I, Lamers CB.

Gastroenterology. 1990 Sep;99(3):621-8.

PMID:
2199288
27.

Pharmacology of pepsinogen secretion: influence of pentagastrin on pepsinogen secretion in man.

Ten Kate RW, Tuynman HA, Festen HP, Pals G, Meuwissen SG.

Hepatogastroenterology. 1990 Feb;37(1):124-7.

PMID:
2107135
28.
29.

Repeated high oral doses of omeprazole do not affect intrinsic factor secretion: proof of a selective mode of action.

Festen HP, Tuynman HA, Den Hollander W, Meuwissen SG.

Aliment Pharmacol Ther. 1989 Aug;3(4):375-9.

PMID:
2518851
30.

[Strong inhibition of gastric acid secretion: advantages and possible hazards].

Festen HP.

Ned Tijdschr Geneeskd. 1989 Apr 1;133(13):653-7. Review. Dutch. No abstract available.

PMID:
2566124
31.

Effects of omeprazole on gastric secretory functions.

Festen HP.

Digestion. 1989;44 Suppl 1:18-24. Review.

PMID:
2691307
32.

The effects of omeprazole and ranitidine on 24-hour pH in the distal oesophagus of patients with reflux oesophagitis.

Klinkenberg-Knol EC, Festen HP, Meuwissen SG.

Aliment Pharmacol Ther. 1988 Jun;2(3):221-7.

PMID:
2979246
33.

Effect of high dose omeprazole on gastric pepsin secretion and serum pepsinogen levels in man.

Ten Kate RW, Tuynman HA, Festen HP, Pals G, Meuwissen SG.

Eur J Clin Pharmacol. 1988;35(2):173-6.

PMID:
3142776
34.

Diagnosis of gastrointestinal lesions during treatment with non-steroidal anti-inflammatory drugs.

Festen HP.

Aliment Pharmacol Ther. 1988;2 Suppl 1:113-9. Review.

PMID:
2979279
35.

Lack of effect of antacids on plasma concentrations of omeprazole given as enteric-coated granules.

Tuynman HA, Festen HP, Röhss K, Meuwissen SG.

Br J Clin Pharmacol. 1987 Dec;24(6):833-5.

36.

Carcinoid tumor of the ampulla of Vater presenting with biliary obstruction: report of four cases.

Mulder CJ, Festen HP, Mertens JC, Huibregtse K, Meuwissen SG, Reeders JW, Tytgat GN.

Gastrointest Endosc. 1987 Oct;33(5):385-7. No abstract available.

PMID:
3119418
37.

Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis.

Klinkenberg-Knol EC, Jansen JM, Festen HP, Meuwissen SG, Lamers CB.

Lancet. 1987 Feb 14;1(8529):349-51.

PMID:
2880161
38.

Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels.

Festen HP, Tuynman HA, Défize J, Pals G, Frants RR, Straub JP, Meuwissen SG.

Dig Dis Sci. 1986 Jun;31(6):561-6.

PMID:
3086061
39.

The influence of omeprazole on the synthesis and secretion of pepsinogen in isolated rabbit gastric glands.

Défize J, Pals G, Frants RR, Westerveld BD, Festen HP, Pronk JC, Meuwissen SG, Eriksson AW.

Biochem Pharmacol. 1985 Oct 15;34(20):3693-9.

PMID:
2996557
40.

[Is endoscopy of the proximal digestive system at the request of the general practitioner useful?].

Lückers AE, Thijs JC, Westerveld BD, Festen HP, Meuwissen SG.

Ned Tijdschr Geneeskd. 1985 Jan 19;129(3):117-9. Dutch. No abstract available.

PMID:
3982525
41.

Effect of oral omeprazole on serum gastrin and serum pepsinogen I levels.

Festen HP, Thijs JC, Lamers CB, Jansen JM, Pals G, Frants RR, Défize J, Meuwissen SG.

Gastroenterology. 1984 Nov;87(5):1030-4.

PMID:
6479529
42.

[Cimetidine and stomach carcinoma].

Festen HP.

Ned Tijdschr Geneeskd. 1981 Nov 21;125(47):1929-31. Dutch. No abstract available.

PMID:
7312068
43.

Is the measurement of blood cimetidine levels useful?

Festen HP, Diemel J, Lamers CB, van Schaik A, Tangerman A, van Tongeren JH.

Br J Clin Pharmacol. 1981 Sep;12(3):417-21.

45.

Cimetidine does not accelerate skin graft rejection in mice.

Festen HP, Berden JH, Koene RA.

Clin Exp Immunol. 1980 Apr;40(1):193-6.

46.

Cimetidine in the treatment of severe ulcerative reflux oesophagitis; results of an 8-week double-blind study and of subsequent long-term maintenance treatment.

Festen HP, Driessen WM, Lamers CB, Van Tongeren JH.

Neth J Med. 1980;23(6):237-40. No abstract available.

PMID:
7007900
47.

Cimetidine in clinical use. A review.

Festen HP, Lamers CB, van Tongeren JH.

Neth J Med. 1980;23(5):210-7. Review. No abstract available.

PMID:
6999368
48.

Cimetidine in anastomotic ulceration after partial gastrectomy.

Festen HP, Lamers CB, Driessen WM, Van Tongeren JH.

Gastroenterology. 1979 Jul;77(1):83-5.

PMID:
376390
49.

Long-term treatment with histamine H2-receptor antagonists in Zollinger-Ellison syndrome.

Lamers CB, Festen HP, van Tongeren JH.

Am J Gastroenterol. 1978 Sep;70(3):286-91.

PMID:
717379
50.

[Cimetidine; new hope for ulcer patients?].

Festen HP, Lamersen CB, van Tongeren JH.

Ned Tijdschr Geneeskd. 1978 Jun 17;122(24):866-70. Review. Dutch. No abstract available.

PMID:
351434

Supplemental Content

Loading ...
Support Center